Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about SMARCA4: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
SMARCA4 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, associated with, inhibits. Associated with AD, ALI, ALS. Connected to 193 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | SMARCA4 |
| Chromosome | 19p13.2 |
| Function | ATP-dependent chromatin remodeling ATPase |
| Primary Expression | the cerebral cortex, hippocampus, and cerebellum |
| Amino Acids | 1647 aa |
| Exons | 35 |
| Pathways | Epigenetic |
| Ensembl ID | ENSG00000127616 |
| GeneCards | SMARCA4 |
| Human Protein Atlas | SMARCA4 |
| Associated Diseases | AD, ALI, Als, AMI, cancer |
| Known Drugs/Compounds | rapamycin |
| Interactions | AND, APOB, ARID1A, ASC, ATG, BECLIN1 |
| SciDEX Hypotheses | Chromatin Remodeling-Mediated Nutrient Sensing Res |
| KG Connections | 320 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
SMARCA4["SMARCA4"] -->|"therapeutic target"| Cancer["Cancer"]
SMARCA4["SMARCA4"] -->|"therapeutic target"| Carcinoma["Carcinoma"]
SMARCA4["SMARCA4"] -->|"therapeutic target"| Ms["Ms"]
SMARCA4["SMARCA4"] -->|"therapeutic target"| Als["Als"]
SMARCA4["SMARCA4"] -->|"therapeutic target"| Fibrosis["Fibrosis"]
SMARCA4["SMARCA4"] -->|"therapeutic target"| Hepatitis["Hepatitis"]
IDH1["IDH1"] -->|"therapeutic target"| SMARCA4["SMARCA4"]
VEGFA["VEGFA"] -->|"therapeutic target"| SMARCA4["SMARCA4"]
MDM4["MDM4"] -->|"therapeutic target"| SMARCA4["SMARCA4"]
APOB["APOB"] -->|"therapeutic target"| SMARCA4["SMARCA4"]
style SMARCA4 fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| SWI/SNF complexes | regulates | complex | 0.90 |
| nucleosome remodeling | activates | process | 0.90 |
| Carcinoma | therapeutic_target | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Cancer | associated_with | disease | 0.75 |
| DNA | associated_with | gene | 0.70 |
| Wnt | therapeutic_target | pathway | 0.70 |
| Colorectal Cancer | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Prostate Cancer | therapeutic_target | disease | 0.65 |
| Infection | therapeutic_target | disease | 0.65 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Cancer | inhibits | disease | 0.65 |
| Tumor | associated_with | disease | 0.65 |
| Colorectal Cancer | associated_with | disease | 0.65 |
| Carcinoma | interacts_with | disease | 0.65 |
| Tumor | activates | disease | 0.65 |
| Ms | interacts_with | disease | 0.65 |
| Inflammatory Bowel Disease | associated_with | disease | 0.65 |
| Carcinoma | inhibits | disease | 0.65 |
| ALS | inhibits | disease | 0.65 |
| Renal Cell Carcinoma | contributes_to | disease | 0.65 |
| Aging | therapeutic_target | disease | 0.65 |
| Lymphoma | therapeutic_target | disease | 0.65 |
| Pulmonary Fibrosis | therapeutic_target | disease | 0.65 |
| Lung Cancer | therapeutic_target | disease | 0.65 |
| Pancreatic Cancer | therapeutic_target | disease | 0.65 |
| Gastric Cancer | therapeutic_target | disease | 0.65 |
| Liver Cancer | therapeutic_target | disease | 0.65 |
| Carcinoma | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| TNF | associated_with | gene | 0.60 |
| RIPK3 | associated_with | gene | 0.60 |
| NOD2 | associated_with | gene | 0.60 |
| BECLIN1 | associated_with | gene | 0.60 |
| ERN1 | associated_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| TNFA | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| NLRP3 | associated_with | gene | 0.60 |
| ASC | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| MET | inhibits | gene | 0.60 |
| Rb | therapeutic_target | protein | 0.60 |
| SQSTM1 | activates | gene | 0.60 |
| STAT3 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-var-a09491064e | targets_gene | hypothesis | 0.90 |
| TERT | therapeutic_target | gene | 0.70 |
| VEGFA | therapeutic_target | gene | 0.70 |
| APOB | therapeutic_target | gene | 0.60 |
| SF3B1 | associated_with | gene | 0.60 |
| MET | therapeutic_target | gene | 0.60 |
| FGF20 | therapeutic_target | gene | 0.60 |
| BRG1 | regulates | gene | 0.60 |
| NRCAM | therapeutic_target | gene | 0.60 |
| NOTCH2 | therapeutic_target | gene | 0.60 |
| EP300 | regulates | gene | 0.60 |
| CTNNB1 | regulates | gene | 0.60 |
| NEUROD1 | therapeutic_target | gene | 0.60 |
| MYC | therapeutic_target | gene | 0.60 |
| ABCB1 | therapeutic_target | gene | 0.60 |
| FOXM1 | regulates | gene | 0.60 |
| LEF1 | therapeutic_target | gene | 0.60 |
| STAT3 | associated_with | gene | 0.60 |
| ASC | associated_with | gene | 0.60 |
| PI3K | associated_with | gene | 0.60 |
| BRG1 | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| NLRP3 | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| PTEN | contributes_to | gene | 0.60 |
| ARID1A | associated_with | gene | 0.60 |
| VHL | contributes_to | gene | 0.60 |
| CD19 | therapeutic_target | gene | 0.60 |
| TP53 | interacts_with | gene | 0.60 |
| SOX11 | therapeutic_target | gene | 0.60 |
| KMT2D | interacts_with | gene | 0.60 |
| NSD2 | interacts_with | gene | 0.60 |
| NOTCH2 | interacts_with | gene | 0.60 |
| NFKBIE | interacts_with | gene | 0.60 |
| CDKN2A | interacts_with | gene | 0.60 |
| MCL1 | therapeutic_target | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| ERN1 | associated_with | gene | 0.60 |
| PYCARD | associated_with | gene | 0.60 |
| NOD2 | associated_with | gene | 0.60 |
| MELK | associated_with | gene | 0.60 |
| CLDN2 | activates | gene | 0.60 |
| ADNP | expressed_in | gene | 0.60 |
| NLGN1 | expressed_in | gene | 0.60 |
| NLGN2 | expressed_in | gene | 0.60 |
| PAX6 | expressed_in | gene | 0.60 |
| ACETYL-COA | contributes_to | gene | 0.60 |
| AMPK | contributes_to | gene | 0.60 |
| WNT | therapeutic_target | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Chromatin Remodeling-Mediated Nutrient Sensing Restoration | 0.764 | neurodegeneration | Epigenetic reprogramming in aging neuron |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 16 hypotheses Top: 0.779
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disea [PMID:33182554] | Marogianni C, Sokratous M, Dardiotis E, | International journal of molec | 2020 | 0 |
| Multiple Sclerosis Pathology. [PMID:29358320] | Lassmann H | Cold Spring Harbor perspective | 2018 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.95 · 2026-04-10
Hypotheses and analyses mentioning SMARCA4 in their description or question text
No additional research found